Flag of the European Union EU Clinical Trials Register Help

Clinical trials for erythropoietin, recombinant

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    73 result(s) found for: erythropoietin, recombinant. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2009-016376-76 Sponsor Protocol Number: 003-12 Start Date*: 2010-04-01
    Sponsor Name:Merck & Co., Inc
    Full Title: A Phase II Extension of a Randomized, Open-Label, Multiple-Rising Dose Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Maintenance of Anemia Treatment in Patients with Chronic Ki...
    Medical condition: Anemia in patients with Chronic kidney disease (CKD)
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-002984-28 Sponsor Protocol Number: CT-830-07-0047 Start Date*: 2008-01-23
    Sponsor Name:STADA R&D GmbH
    Full Title: Evaluation of the Therapeutic Equivalence of Two Different Formulations Containing Epoetin (Epoetin STADA vs. Erypo®) Administered Subcutaneously for the Maintenance Treatment of Renal Anaemia
    Medical condition: To prove the therapeutic equivalence of Epoetin STADA to a reference product (Erypo®) administered subcutaneously for maintaining the haemoglobin concentration in anaemic patients with end-stage re...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BG (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-004929-28 Sponsor Protocol Number: GMX.RFM006 Start Date*: 2008-10-01
    Sponsor Name:GeneMedix plc
    Full Title: Prospective, Multicentre, Randomised, Double-Blind, Parallel Group Study Comparing the Therapeutic Biosimilarity of Epostim (GMX) with Eprex (J&J) when given Intravenously to Patients undergoing Ch...
    Medical condition: Renal failure patients with anaemia on chronic haemodialysis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009120 Chronic renal failure anaemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: LT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2009-010904-27 Sponsor Protocol Number: MK-2578-003 Start Date*: 2009-09-07
    Sponsor Name:MERCK & CO., INC.
    Full Title: A Phase II Randomized, Open-Label, Multiple-Rising Dose Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Maintenance of Anemia Treatment in Patients With Chronic Kidney Disease...
    Medical condition: Anemia in patient with Kidney Disease (CKD)
    Disease: Version SOC Term Classification Code Term Level
    12.0 10009120 Chronic renal failure anaemia LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended) BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-004857-14 Sponsor Protocol Number: 1 Start Date*: 2009-05-29
    Sponsor Name:Psykiatrisk Center Rigshospitalet
    Full Title: The effects of erythropoietin on depressive symptoms and neurocognitive deficits in patients with treatment resistant depression and in patients with remitted bipolar disorder – a proof of concept ...
    Medical condition: Treatment resistant depression and bipolar disorder in remission.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050648 Blood erythropoietin LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2008-004340-37 Sponsor Protocol Number: HX575-305 Start Date*: 2008-11-11
    Sponsor Name:Hexal Biotech ForschungsGmbH
    Full Title: An open label, multinational, multicenter study to evaluate the safety of HX575 recombinant human erythropoietin alfa
    Medical condition: Subjects with chronic kidney disease (CKD) previously enrolled in other efficacy and/or safety studies with HX575, after these subjects have participated in the earlier study.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009120 Chronic renal failure anaemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SK (Prematurely Ended) DE (Completed) ES (Completed) BE (Completed) FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-005125-11 Sponsor Protocol Number: RCT-EPO-001 Start Date*: 2008-12-19
    Sponsor Name:Walton Centre for Neurology and Neurosurgery
    Full Title: A pilot single-centre randomised controlled trial of recombinant human erythropoietin versus placebo in primary progressive multiple sclerosis.
    Medical condition: Primary progressive multiple sclerosis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10063401 Primary progressive multiple sclerosis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-013286-26 Sponsor Protocol Number: 002 Start Date*: 2010-04-29
    Sponsor Name:Merck & Co., Inc.
    Full Title: A Phase IIb, Randomized, Active Comparator-Controlled, Open-Label Clinical Trial to Study the Efficacy and Safety of MK-2578 for the Treatment of Anemia in ESA (Erythropoiesis-Stimulating Agent)-Na...
    Medical condition: Correction of anemia in ESA-naïve patients with chronic kidney disease (CKD) who are not on dialysis.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: BG (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-000140-85 Sponsor Protocol Number: XM01-04 Start Date*: 2005-07-05
    Sponsor Name:BioGeneriX AG
    Full Title: Efficacy and Safety of subcutaneous administration of XM01 and Epoetin beta for treatment of anaemia in chronic renal failure patients not yet receiving dialysis. A multinational, multicentre, rand...
    Medical condition: treatment of anaemia in chronic renal failure patients not yet receiving dialysis
    Disease: Version SOC Term Classification Code Term Level
    8.0 10054353 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2005-000144-87 Sponsor Protocol Number: XM01-08 Start Date*: 2005-12-23
    Sponsor Name:BioGeneriX AG
    Full Title: Long-term efficacy and safety of subcutaneous administration of XM01 in chronic renal failure patients and comparison of once-weekly with three-times weekly administration of XM01 - A multinational...
    Medical condition: Treatment of anaemia in chronic renal failure patients
    Disease: Version SOC Term Classification Code Term Level
    8.0 10054353 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2006-002938-38 Sponsor Protocol Number: MHH – EPONTX – 01/06 Start Date*: 2006-11-17
    Sponsor Name:Hannover Medical School
    Full Title: EFFECT OF ERYTHROPOIETIN ON RENAL FUNCTION AFTER KIDNEY TRANSPLANTATION
    Medical condition: We will investigate the effect of recombinant human erythropoietin (rHuEPO) on ischemia-reperfusion injury in patients with terminal renal failure undergoing cadaveric kidney transplantation. In th...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-002326-36 Sponsor Protocol Number: 2016-858 Start Date*: 2016-11-09
    Sponsor Name:Region Hovedstadens psykiatriske hospital
    Full Title: Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T)
    Medical condition: Unipolar/bipolar depression
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004873 10045543 Unipolar depression LLT
    21.1 100000004873 10004936 Bipolar depression LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2005-000142-37 Sponsor Protocol Number: XM01-06 Start Date*: 2005-06-13
    Sponsor Name:BioGeneriX AG
    Full Title: Efficacy and Safety of subcutaneous administration of XM01 compared to Epoetin beta in anaemic chronic renal failure patients not yet receiving dialysis and in maintenance phase treatment with Epoe...
    Medical condition: anaemic chronic renal failure patients not yet receiving dialysis
    Disease: Version SOC Term Classification Code Term Level
    9 10009119 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed)
    Trial results: View results
    EudraCT Number: 2016-000541-31 Sponsor Protocol Number: 200807 Start Date*: 2016-12-02
    Sponsor Name:GlaxoSmithKline Research & Development Ltd
    Full Title: A phase 3 randomized, open-label (sponsor-blind), activecontrolled, parallel-group, multi-center, event driven study in dialysis subjects with anemia associated with chronic kidney disease to evalu...
    Medical condition: Anemia associated with chronic kidney disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038359 - Renal and urinary disorders 10064848 Chronic kidney disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: HU (Completed) BE (Completed) GB (GB - no longer in EU/EEA) DK (Completed) CZ (Completed) DE (Completed) SE (Completed) PT (Completed) ES (Completed) NL (Completed) AT (Completed) GR (Completed) FR (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-005259-32 Sponsor Protocol Number: Eprotection/2007/05 Start Date*: 2005-04-27
    Sponsor Name:Imperial College Heathcare NHS Trust
    Full Title: A phase 2 randomised trial to investigate the effects of recombinant human erythropoietin on infarct size in patients undergoing primary percutaneous coronary angiography for ST-segment elevation m...
    Medical condition: Acute ST elevation myocardial infarction
    Disease: Version SOC Term Classification Code Term Level
    9.1 10000891 Acute myocardial infarction LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: View results
    EudraCT Number: 2006-003819-45 Sponsor Protocol Number: GE IDE No. I01106 Start Date*: 2007-01-07
    Sponsor Name:Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München
    Full Title: PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ERYTHROPOIETIN IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION. REVIVAL-...
    Medical condition: Patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10000891 Acute myocardial infarction LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005373-22 Sponsor Protocol Number: 10322 Start Date*: 2007-07-23
    Sponsor Name:Central Manchester and Manchester Children's University Hospitals NHS Trust
    Full Title: Erythropoietin and Delayed Graft Function in Renal Allografts from Extended Criteria Donors.
    Medical condition: Transplantation of renal allografts from extended criteria donors
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2014-000612-34 Sponsor Protocol Number: EpoRepair Start Date*: 2015-12-15
    Sponsor Name:UniversitätsSpital Zürich
    Full Title: Erythropoietin for the repair of cerebral injury in very preterm infants, a randomized, double-blind, placebo-controlled, prospective, and multicenter clinical study
    Medical condition: 1 out of 100 children born extremely early, or more than 8 weeks before the expected date. 20% of these extremely preterm children shows a cerebral hemorrhage at birth, leading to a significantly i...
    Disease:
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-005344-25 Sponsor Protocol Number: HCV 07-01 Start Date*: 2008-03-19
    Sponsor Name:Foundation for Liver Research
    Full Title: High-dose versus standard-dose weight-based ribavirin in combination with peginterferon alfa-2a for patients infected with hepatitis C virus genotype 1 or 4
    Medical condition: Chonic hepatitis C
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-002255-10 Sponsor Protocol Number: IRMINEpilot Start Date*: 2016-06-30
    Sponsor Name:Abertawe Bro Morgannwg University Health Board
    Full Title: INFLAMMATORY RESPONSE IN MAJOR INJURY & RECOMBINANT HUMAN ERYTHROPOIETIN (IRMINE) - A PILOT STUDY
    Medical condition: Post-trauma multiple organ failure: a manifestation of the systemic inflammatory/immune response to major injuries.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004870 10021459 Immunodeficiency secondary to trauma LLT
    20.0 100000004867 10028237 Multiple organ failure LLT
    20.0 10022117 - Injury, poisoning and procedural complications 10044461 Trauma LLT
    20.0 10022117 - Injury, poisoning and procedural complications 10044541 Traumatic shock PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 07 07:58:17 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA